URL details: immunext.com

URL title: ImmuNext – Developing novel immunotherapies for autoimmune disease and cancer
URL paragraphs: ImmuNext's anti-CD40L antagonist enters THIRD Sanofi-led Phase 2 trial NCT05039840 ImmuNext Inc. P.O. Box 9 Alton, NH 03809 Email: [email protected] © 2024 ImmuNext. All Rights Reserved, ImmuNext Inc.
URL last crawled: 2024-07-26
URL speed: 0.837 MB/s, downloaded in 0.050 seconds

open external url

We found no external links pointing to this url.